All Pharma News
Docquity enables Italian biopharma company Menarini

Docquity enables Italian biopharma company Menarini
BIOSPECTRUM ASIA
20 Mar 2024
Share Share
Venatorx and Menarini Enter Agreement for Cefepime-Taniborbactam

Venatorx and Menarini Enter Agreement for Cefepime-Taniborbactam
BUSINESSWIRE
09 Jan 2024
Share Share
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement
BUSINESSWIRE
04 Jan 2024
Share Share
Menarini Presented Efficacy Data from Phase 1b/2 Combination Studies of ORSERDU

Menarini Presented Efficacy Data from Phase 1b/2 Combination Studies of ORSERDU
PR NEWSWIRE
11 Dec 2023
Share Share
Menarini Presented Efficacy Data from Phase 1b/2 Studies of ORSERDU

Menarini Presented Efficacy Data from Phase 1b/2 Studies of ORSERDU
BUSINESSWIRE
11 Dec 2023
Share Share
Menarini Presents Progression-Free Survival Data from EMERALD Clinical Study

Menarini Presents Progression-Free Survival Data from EMERALD Clinical Study
BUSINESSWIRE
08 Dec 2023
Share Share
Menarini Group Announces New Data on ORSERDU® (elacestrant) at Symposium

Menarini Group Announces New Data on ORSERDU® (elacestrant) at Symposium
PR NEWSWIRE
21 Nov 2023
Share Share
Menarini Group Announces New Data on ORSERDU

Menarini Group Announces New Data on ORSERDU
BUSINESSWIRE
20 Nov 2023
Share Share
Menarini and SciClone Pharma Announce Exclusive Sub-Licensing Collaboration

Menarini and SciClone Pharma Announce Exclusive Sub-Licensing Collaboration
BUSINESSWIRE
07 Nov 2023
Share Share
European Organisation for Research & Menarini Launch Trial in Breast Cancer

European Organisation for Research & Menarini Launch Trial in Breast Cancer
PR NEWSWIRE
19 Oct 2023
Share Share